Direct answer: A mental health crisis needs prompt help when someone may harm themselves or another person, cannot remain safe, or has severe new disturbance such as psychosis or confusion. Warning signs are reasons to act, not a diagnostic checklist or a reliable calculator of future suicide risk. Confidence is high in the need for appropriate assessment and safety review, and moderate in this selected summary of clinical care pathways. A supplement substitute is not independently established here. Recommendations are not relabeled as clean, independently replicated trial results (NIMH suicide warning signs).
Key takeaways
- A mental health crisis needs prompt help when someone may harm themselves or another person, cannot remain safe, or has severe new disturbance such as psychosis or confusion.
- A crisis plan can clarify contacts and practical steps, but it is not a guarantee against harm.
- If someone has acted on a suicide attempt, has an overdose or cannot be kept safe, seek emergency help now.
Table of contents
- Evidence summary
- What it is
- How it works
- The evidence-based treatments
- Supplement and lifestyle evidence
- What works and what does not
- Risks and side effects
- Important interactions
- Who should avoid unsupervised treatment
- Dosage and how to take
- Animal and in-vitro evidence
- Funding and source roles
- Frequently asked questions
- Sources and funding notes
Evidence summary
The source roles below are deliberately different. A health-agency explanation can support definitions and a clinical guideline can describe recommended care; neither automatically clears the funding of its supporting trials. This selected review does not provide a newly pooled treatment-effect estimate.
| Question | Source | Funding / conflict | Interpretation and limits |
|---|---|---|---|
| What needs assessment? | NIMH suicide warning signs | Public institutional education; complete individual disclosures may be unavailable. | Clinical background; no online self-diagnosis. |
| Which care options are discussed? | NIMH finding help; NIMH psychotherapies | Institutional funding checked; every supporting trial has not been screened. | Recommendation/context role; no sponsor-independent effect size claimed. |
| What are medicine and safety limits? | NIMH mental health medications; NIMH suicide warning signs | US publicly funded education. | General precautions; individual decisions require clinical review. |
| Can supplements replace care? | NCCIH anxiety and complementary approaches | Public summary; included-study finances vary. | No independently verified replacement regimen established in this review. |
What it is
NIMH identifies suicidal talk, hopelessness, feeling trapped or burdensome, preparations, giving away possessions and marked behavioural change as possible warning signs. No list captures every crisis, and absence of those signs does not prove safety. Ask directly about immediate danger and take the answer seriously. A person with a known diagnosis can develop a different emergency too. Sudden severe symptoms after childbirth deserve particular attention because postpartum psychosis is a medical emergency. New confusion, intoxication, an overdose or a physical injury may require medical treatment alongside psychiatric care. (NIMH suicide warning signs).
How it works
Crisis risk is dynamic and can change with distress, substances, access to means, illness and circumstances. A risk factor is not a prediction for an individual. Conversely, a reassuring screening score cannot substitute for an assessment of the present situation. The point of recognizing warning signs is to obtain help and reduce immediate danger, not to decide independently that someone belongs in a low-risk category. (NIMH suicide warning signs).
The evidence-based treatments
For immediate danger, use local emergency services and explain the specific concern. NIMH gives US crisis routes: 988 for crisis support and 911 for life-threatening emergencies. Those numbers are not a universal international service. Elsewhere, use the applicable local urgent mental health or emergency route. If it can be done safely, stay with the person while obtaining help, involve an appropriate trusted support and reduce access to dangerous means. Do not make a promise to keep imminent danger secret. Assessment may require urgent medical care, specialist psychiatric review or a safety plan and follow-up. A hotline conversation should not delay emergency treatment for an overdose or serious injury. (NIMH suicide warning signs; NIMH finding help).
Supplement and lifestyle evidence
Food, sleep and social support can matter to recovery, but a lifestyle routine is not emergency treatment. A supplement or relaxation response cannot establish that an overdose, psychosis or suicidal intent is safe. Complementary products can also complicate medicines and should be disclosed to the team (NIMH mental health medications).
What works and what does not
A crisis plan can clarify contacts and practical steps, but it is not a guarantee against harm. A verbal promise, a brief improvement or a supplement that calms someone does not establish that the danger has passed. The next step depends on the current situation and professional assessment.
Risks and side effects
If someone has acted on a suicide attempt, has an overdose or cannot be kept safe, seek emergency help now. Do not rely on this article to decide that an ingestion is harmless. Avoid putting yourself in danger while assisting another person.
Thoughts of suicide, a plan to act, or inability to keep yourself or another person safe need urgent help. In an immediate danger, contact local emergency services; in the United States, 988 provides crisis support and 911 is for life-threatening emergencies. These numbers are jurisdiction-specific. Tell a trusted person and obtain help rather than relying on an article or supplement. If someone is at immediate risk, do not leave them alone while arranging safe assistance (NIMH suicide warning signs).
Medicines can cause unwanted effects and some require monitoring or a gradual stopping plan. New agitation, marked behavioural change or worsening suicidal thoughts should be reported promptly, particularly around starting or changing an antidepressant. A difficult therapy session should be discussed too; agreed pacing and safety matter (NIMH mental health medications).
Important interactions
Alcohol, recreational drugs, sedating medicines or a recent medication change may affect the emergency picture. Tell responders what is known, including any suspected ingestion. Do not give an unprescribed sedative or combine calming products in an attempt to manage a crisis. (NIMH mental health medications; NIMH psychotherapies).
Who should avoid unsupervised treatment
Anyone with imminent safety concerns should avoid substituting an article, online test or routine future appointment for urgent help. Children, vulnerable adults and postpartum patients may need specific safeguarding and specialist pathways. (NIMH finding help).
Dosage and how to take
No calming-product dose or home crisis regimen is provided. Contact the appropriate service, describe the immediate concern and follow its instructions. A planned treatment course can be discussed after urgent safety and medical needs have been addressed. (NIMH finding help).
Animal and in-vitro evidence
Changes in stress hormones, neurotransmitters or behaviour in cells or animals are clues to mechanisms. They cannot establish clinical recovery, functional improvement or safety in a person with this clinical or occupational problem. Nor does laboratory activity identify the right human product, formulation or dose. This article excludes animal and cell findings from human efficacy conclusions. Mechanistic plausibility is kept separate from the clinical guidance summarized above.
Funding and source roles
Who paid for the evidence?
Follow named sources to the funding and relationships disclosed in this article. Numbered article disclosures preserve notes where a source is not identified. A public or university name alone does not establish independence.
View 4 more funding disclosures
This graphic reorganizes the article's disclosures; it is not a new financial audit or independence classification. Highlighted notes show different funding relationships where available. Review funding is separate from underlying trial funding. Disclosure is not proof of falsehood, and no declared conflict is not proof of complete independence.
Tier describes financial independence; the letter grade describes credibility for the stated use, not treatment potency. The source mix is concentrated in US and UK institutions, with international sources where indicated. Public funding is checked but does not erase individual or trial-level ties. Medicine, device, therapy, app and supplement providers may earn revenue from care; clinicians and institutions also have professional and service incentives. Those interests do not establish misconduct or a payment to this article.
| Source | Funding / backers | Country / jurisdiction | Independence | Credibility / incentives / gaps |
|---|---|---|---|---|
| NIMH suicide warning signs | US NIH/HHS federal appropriations; NIMH budget route. NIMH also accepts donations and bequests through its separate Gift Fund, which can support public information. Page-specific donor allocation and individual contributor finances were not established. | United States; Bethesda, Maryland; federal health research agency. | Tier 1 public appropriations plus disclosed donation route; page-level independence provisional and underlying trial finances vary. | B, provisional: public accountability and scientific reputation reward accuracy. Education is simplified; the institution also promotes its research mission. No blanket trial clearance. |
| NIMH finding help | US NIH/HHS federal appropriations; NIMH budget route. NIMH also accepts donations and bequests through its separate Gift Fund, which can support public information. Page-specific donor allocation and individual contributor finances were not established. | United States; Bethesda, Maryland; federal health research agency. | Tier 1 public appropriations plus disclosed donation route; page-level independence provisional and underlying trial finances vary. | B, provisional: public accountability and scientific reputation reward accuracy. Education is simplified; the institution also promotes its research mission. No blanket trial clearance. |
| NIMH caring for mental health | US NIH/HHS federal appropriations; NIMH budget route. NIMH also accepts donations and bequests through its separate Gift Fund, which can support public information. Page-specific donor allocation and individual contributor finances were not established. | United States; Bethesda, Maryland; federal health research agency. | Tier 1 public appropriations plus disclosed donation route; page-level independence provisional and underlying trial finances vary. | B, provisional: public accountability and scientific reputation reward accuracy. Education is simplified; the institution also promotes its research mission. No blanket trial clearance. |
| NHS postpartum psychosis | Public NHS health-service institution; dated 2019/20 public accounts. Current page-level budget, outside contributors and trial finances not verified. | United Kingdom; England NHS website/service unless the source states another NHS jurisdiction. | Tier 1 public institution, provisional; not an audit of every contributor or underlying study. | B, provisional: patient-safety accountability and transparent service role. Educational simplification, local care pathways and service priorities remain limitations. Funding records cited are dated. |
| NIMH psychotherapies | US NIH/HHS federal appropriations; NIMH budget route. NIMH also accepts donations and bequests through its separate Gift Fund, which can support public information. Page-specific donor allocation and individual contributor finances were not established. | United States; Bethesda, Maryland; federal health research agency. | Tier 1 public appropriations plus disclosed donation route; page-level independence provisional and underlying trial finances vary. | B, provisional: public accountability and scientific reputation reward accuracy. Education is simplified; the institution also promotes its research mission. No blanket trial clearance. |
| NIMH mental health medications | US NIH/HHS federal appropriations; NIMH budget route. NIMH also accepts donations and bequests through its separate Gift Fund, which can support public information. Page-specific donor allocation and individual contributor finances were not established. | United States; Bethesda, Maryland; federal health research agency. | Tier 1 public appropriations plus disclosed donation route; page-level independence provisional and underlying trial finances vary. | B, provisional: public accountability and scientific reputation reward accuracy. Education is simplified; the institution also promotes its research mission. No blanket trial clearance. |
| NCCIH anxiety and complementary approaches | US NIH/HHS public appropriations; funding-process documentation. This dated request is not a verified current allocation. NIH gift authority permits conditional and unconditional gifts; actual NCCIH page-specific donor support was not established. | United States; Bethesda, Maryland; federal institution. | Tier 1 institution, provisional; supporting study funding not cleared. | B, provisional: public safety remit and research accountability. Complementary-health research mission and selective summaries remain relevant. Used for limits and safety, not a clean product-effect estimate. |
Frequently asked questions
Should I ask about suicide directly?
NIMH advises direct discussion and taking concerns seriously. It is not a reason to avoid the subject.
Are 988 and 911 worldwide?
No. These are US routes; use local services in your jurisdiction.
Can improvement after talking prove safety?
No. Present danger and follow-up still require appropriate assessment.
Sources and funding notes
Original source pages were opened for this review, including recommendation text where a guideline is cited. The institution-level funding routes were checked; page-level contributors, guideline declarations and the full financial chain of supporting studies are not all cleared. Public recommendations are therefore reported as guidance, and no drug, device or supplement is assigned an independently verified effect size. Source dates vary and some pages predate the review. This is an educational, selected review rather than an exhaustive systematic search or personal medical advice.
- NIMH suicide warning signs — Revised 2023
- NIMH finding help — Last Reviewed: April 2026
- NIMH caring for mental health — Last Reviewed: April 2026
- NHS postpartum psychosis — Page last reviewed: 18 October 2023
- NIMH psychotherapies — Last Reviewed: February 2024
- NIMH mental health medications — Last Reviewed: December 2023
- NCCIH anxiety and complementary approaches — Last Updated: September 2024
Last reviewed: October 4, 2026.
Have a question — or want us to cover something?
Ask about anything on this page, or request the next deep dive: an ingredient, a supplement, or a health concern. We use published research, evidence syntheses, and regulatory guidance, with clear source links.
One daily research roundup
Get the topics, key findings and links from our new articles in one email. At most one digest a day, only when there is something new.